BioWorld MedTech
Archive Search

User ID

Password

Forgot password

Remember my login



New User ?

BioWorld MedTech Twitter

Clarivate Analytics

Today's Issue of BioWorld MedTech

Wednesday, July 26, 2017

Today's Headlines

Siemens to buy POC diagnostic hand-held unit from Abbott to quell merger monopoly fears

The European Commission and the Federal Trade Commission put Chicago, Ill.-based Abbott in a tough place with its merger with Waltham, Mass-based Alere Inc. The agencies noted that Abbott would hold both of the marketed hand-held, point-of-care blood diagnostic systems, its own I-stat and Alere's Epoc, after the deal completes.

Shares of med-tech firms surge as investors warm to sector, driven by optimism

Like their biopharmaceutical colleagues, publicly listed medical technology companies have roared out of the gate this year as investors flood back into health care. Companies have benefited from record-breaking market highs being driven by a increased optimism that the U.S. economy is poised to enjoy better times ahead.

Device deals climb with a focus on cancer, cardiovascular markets

The number of medical device deals and their disclosed values appear to be rising, according to data from Cortellis Deals Intelligence (CDI). CDI reported 202 med-tech deals in 2014, compared with 237 deals in 2015 and 287 deals in 2016. The total value of deals was $22.85 million in 2014, $251.06 million in 2015 and $1.54 billion in 2016.


Home   |   About Us   |   Contact Us   |   Copyright Notices   |   Terms of Use   |   Privacy Statement

clarivate.com | BioWorld.com | bioworldmedtech.com